REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Hitgen Inc. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Hitgen Inc. Profile Updated: December 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Hitgen Inc. is in the business of innovative drug discovery. The company provides DNA Encoded Library and screening technology for the R&D of drugs on major diseases such as oncology, cardiovascular, respiratory and metabolism etc. The company was established in 2012, headquartered in Chengdu City, China.

Headquarters
Tianfu International Biological City, Chengdu, Sichuan Province (No. 18, Section 2, Middle Biological City Road, Shuangliu District)
Chengdu; Sichuan; Postal Code: 610200

Contact Details: Purchase the Hitgen Inc. report to view the information.

Website: http://www.hitgen.com

Basic Information
Total Employees:
Purchase the Hitgen Inc. report to view the information.
Outstanding Shares:
Purchase the Hitgen Inc. report to view the information.
Registered Capital:
Purchase the Hitgen Inc. report to view the information.
Financial Auditors:
Purchase the Hitgen Inc. report to view the information.
Incorporation Date:
February 22, 2012
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
20.43%
Purchase this report to view the information.
12.82%
Purchase this report to view the information.
9.65%
Purchase this report to view the information.
6.6%
Purchase this report to view the information.
4.1%
Subsidiaries
Chengdu Kehui Leading Pharmaceutical R&D Co., Ltd.
100%
Chengdu Pilot Nucleic Acid Biotechnology Co., Ltd.
100%
Chongqing Lead Protein Technology Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Hitgen Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
21.38%▲
Total operating revenue
13.56%▲
Operating profit (EBIT)
255.33%▲
Net Profit (Loss) for the Period
55.47%▲
Total assets
1.57%▲
Total equity
3.14%▲
Operating Profit Margin (ROS)
5.74%▲
Net Profit Margin
2.11%▲
Return on Equity (ROE)
0.69%▲
Debt to Equity Ratio
-0.94%▼
Quick Ratio
-0.08%▼
Cash Ratio
1.73%▲

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
Nanjing Pharmaceutical Company Limited
Chongqing Zhifei Biological Products Co.,Ltd.
 
Hubei Biocause Pharmaceutical Co.,Ltd.
Staidson (Beijing) Biopharmaceuticals Co., Ltd. (舒泰神(北京)生物制药股份有限公司)
 
Ji Yao Holding Group Co., Ltd.
Fujian Cosunter Pharmaceutical Co., Ltd.
 
Tibet Duo Rui Pharmaceutical Co., Ltd.
Qilian International Holding Group Ltd.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo